Who owns GSK consumer healthcare?
Under GSK’s plan, shareholders will receive stock in the new consumer health group amounting to at least 80% of the 68% stake that GSK currently owns in it. Pfizer owns the remaining 32%.
What is consumer healthcare?
Consumer healthcare deals with products in wellness, oral health, nutrition, and skin health. Consumer healthcare products mainly constitute over-the-counter (OTC) drugs that include medicines, which are sold directly to a consumer without a prescription from a healthcare professional.
What are GSKS main products?
We are one of the world’s largest providers of specialist oral health. With a broad range of science-based products, such as Sensodyne, parodontax and Polident, our goal is to make the world’s mouths healthier.
Is GSK FMCG?
HUL-GSK merger complete, FMCG giant buys Horlicks brand for ₹3,045 crore. NEW DELHI : Hindustan Unilever Ltd (HUL) has completed the merger of GlaxoSmithKline Consumer Healthcare Limited (GSKCH) with itself, over a year after the Rs31,700 crore mega-deal was first announced.
Where is GSK consumer healthcare located?
Warren, NJ
Glaxosmithkline Consumer Healthcare Holdings (us) LLC is located in Warren, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry.
How did GSK Consumer Healthcare start in India?
In the Indian market, GSK Consumer Healthcare’s journey began with Horlicks. In the early years, Horlicks, manufactured by Horlicks Limited, Slough, England was being imported, bottled and sold in India. The year 1955 saw a change in the import policy following which the import of Horlicks was stopped.
What is the share capital of GlaxoSmithKline Consumer Healthcare?
Glaxosmithkline Consumer Healthcare Limited is a Public incorporated on 30 October 1958. It is classified as Non-govt company and is registered at Registrar of Companies, Chandigarh. Its authorized share capital is Rs. 600,000,000 and its paid up capital is Rs. 420,555,392.
How many manufacturing sites does GSK have in the world?
GSK has more than 80 manufacturing sites globally and have our R&D into two major hubs, in Stevenage, UK, and in Philadelphia, US. Click here to see the annual report